About The Study: In this decision analytical modeling study, the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050 was estimated to be $25.2 trillion (in international dollars at constant 2017 prices). The economic burden and the health burden were distributed unequally across countries, world regions, and country income groups. The results of this study suggest that global efforts to contain projected increases in the burden of cancers are warranted.
Authors: Simiao Chen, Sc.D., of the Heidelberg Institute of Global Health in Heidelberg, Germany, and Chen Wang, M.D., Ph.D., of the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing, are the corresponding authors.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2022.7826)
